“Biomedicines”, published a peer-reviewed review article* on real-world data showing the effectiveness of our cancer screening test “N-NOSE”.

TOKYO, CHIYODA-KU, JAPAN, November 20, 2024 /EINPresswire.com/ -- HIROTSU BIO SCIENCE INC. (Head Office: Tokyo; Representative; Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”)), is proud to announce that the international biomedical journal “Biomedicines”, published a peer-reviewed review article* on real-world data showing the effectiveness of “N-NOSE”.

N-NOSE Proves Effective for Early Cancer Detection: Real-World Data from Third-Party Medical Institutions. Nakajo N., et al., Biomedicines, 12, 2546 (2024)
https://www.mdpi.com/2227-9059/12/11/2546

This review explains the effectiveness and accuracy of “N-NOSE” based on real-world data obtained from independent, multicenter, third-party medical institutions.

Main points of the review

1. Improvement of cancer detection rates
The cancer detection rate of PET screening tests triggered by “N-NOSE” was 2.96%
compared to conventional PET screening which was 1.31%.

2. High positive predictive value (PPV)
The apparent PPV of PET/CT, without considering its sensitivity, was 2.09%. However, after adjusting for the sensitivity of PET/CT, the true PPV of “N-NOSE” reached approximately 11.7%. This demonstrates a screening efficiency 14.6 times higher compared to the cancer incidence rate in the general population (approximately 0.8%).

This review, based on real-world data from Japan, highlights that the nematode cancer test offers high cost-effectiveness for asymptomatic individuals and holds great potential as a minimally invasive primary cancer screening tool.

▼Review the whole article (external and same link as above)
https://www.mdpi.com/2227-9059/12/11/2546

*Peer Review
“Peer review” refers to the process in which multiple independent third-party experts with an international perspective rigorously evaluate a research paper to determine its suitability for publication before it is released. This process seeks to improve the reliability of the paper through expert scrutiny. It has been a long-established system in the scientific community. A “peer-reviewed paper” is one that has passed through this rigorous and objective evaluation by specialists before being published.

■ About HIROTSU BIO SCIENCE
As a researcher, company CEO Hirotsu saw potential in nematodes’ habit and developed a primary cancer screening test called “N-NOSE^®”. With this unique technology and talented researchers, we aim to create a world where cancer can be detected early, protecting people’s health and securing a safer future.

Company Name : HIROTSU BIO SCIENCE INC.
Headquarters : 22F New Otani Garden Court, 4-1 Kioi-cho, Chiyoda-ku, Tokyo
Representative : Takaaki Hirotsu, CEO
Date of Establishment : August 2016
Main Service : Research, development, and marketing of cancer screenings using nematodes and nematode olfactory sensors.
Official Website : https://hbio.jp/en/

■ About “N-NOSE^®”
A primary cancer screening test that leverages the highly accurate ability of the nematode C. elegans to detect cancer-specific odors. “N-NOSE^®” is simple, non-invasive, and inexpensive. By simply submitting urine, you can get a whole-body examination of early-stage cancer risks.
Official Website: https://lp.n-nose.com/

■ About “N-NOSE^® plus Pancreas”
“N-NOSE^® plus Pancreas” uses a "special nematode" genetically engineered from the nematode C. elegans that specifically reacts only to the smell of pancreatic cancer.
Related Press Release: 　https://hbio.jp/news/en/2023/01/20230104/


■ About “N-NOSE^® Animals”
We applied “N-NOSE^®“ technology to our beloved pets and developed “N-NOSE^® Dogs” and “N-NOSE^® Cats”. Before “N-NOSE^® Animals”, there were not any simple and accessible cancer screening tests for pets. Just like “N-NOSE^®“ for humans, “N-NOSE^® Animals” can easily detect cancer risks only with a drop of urine from both cats and dogs.
N-NOSE^® Dogs : https://hbio.jp/news/en/2023/05/cancer-test-for-dogs-n-nose-plus-dogs-service-launch-from-tuesday-may-9/
N-NOSE^® Cats : https://hbio.jp/news/en/2023/10/20231012/

HIROTSU BIO SCIENCE PR
HIROTSU BIO SCIENCE INC.
press@hbio.jp

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.